CANTEL MEDICAL CORP's ticker is CMD and the CUSIP is 138098108. A total of 219 filers reported holding CANTEL MEDICAL CORP in Q1 2017. The put-call ratio across all filers is 1.90 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $276,000 | -79.4% | 3,540 | -79.2% | 0.11% | -69.8% |
Q4 2016 | $1,338,000 | -15.7% | 16,991 | -16.6% | 0.36% | -5.8% |
Q3 2016 | $1,588,000 | -9.0% | 20,363 | -19.8% | 0.38% | +18.4% |
Q2 2016 | $1,745,000 | -17.4% | 25,384 | -14.3% | 0.32% | +5.6% |
Q1 2016 | $2,113,000 | -24.1% | 29,606 | -33.9% | 0.30% | +1.3% |
Q4 2015 | $2,785,000 | +246.0% | 44,819 | +164.3% | 0.30% | +279.7% |
Q1 2015 | $805,000 | -57.1% | 16,956 | -60.9% | 0.08% | -55.9% |
Q4 2014 | $1,878,000 | +187.6% | 43,408 | +128.4% | 0.18% | +214.0% |
Q3 2014 | $653,000 | -70.8% | 19,008 | -68.8% | 0.06% | -67.6% |
Q2 2014 | $2,234,000 | +42.9% | 60,999 | +31.6% | 0.18% | +70.9% |
Q1 2014 | $1,563,000 | -22.1% | 46,358 | -21.6% | 0.10% | +8.4% |
Q4 2013 | $2,006,000 | +59.3% | 59,158 | +49.7% | 0.10% | +66.7% |
Q3 2013 | $1,259,000 | +32.0% | 39,527 | +40.4% | 0.06% | +42.5% |
Q2 2013 | $954,000 | – | 28,159 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DIKER MANAGEMENT LLC | 1,084,317 | $85,509,000 | 43.23% |
Leonard Green & Partners, L.P. | 2,100,000 | $165,606,000 | 2.29% |
Champlain Investment Partners, LLC | 3,952,620 | $311,704,000 | 1.79% |
Brown Capital Management | 2,454,770 | $193,583,000 | 1.34% |
Aurora Investment Counsel | 19,502 | $1,538,000 | 1.24% |
Conestoga Capital Advisors, LLC | 797,481 | $62,889,000 | 1.00% |
EMERALD ADVISERS, LLC | 292,554 | $23,071,000 | 0.77% |
FRED ALGER MANAGEMENT, LLC | 3,470,340 | $273,671,000 | 0.71% |
GENEVA CAPITAL MANAGEMENT LLC | 510,171 | $40,232,000 | 0.68% |
WASHINGTON CAPITAL MANAGEMENT, INC | 7,650 | $603,000 | 0.58% |